Overview Maxigesic 325 Acute Dental Pain Study Status: Completed Trial end date: 2015-01-01 Target enrollment: Participant gender: Summary The purpose of this study is to determine whether the analgesic effects of Maxigesic USA are greater than acetaminophen, ibuprofen or placebo. Phase: Phase 3 Details Lead Sponsor: AFT Pharmaceuticals, Ltd.Treatments: AcetaminophenIbuprofen